This inventor holds 2 USPTO granted patents. Top assignees: Novartis Ag, Novartis Corporation, Ucp Gen-Pharma Ag. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Munich, DE (1999)
- Munchen, DE (1999)
Company Filing History:
1 out of 3,978 
1 out of 166 
1 out of 8 Years Active: 1999
Title: Christian Sommerhoff: Innovator in Serine Protease Inhibitors
Introduction
Christian Sommerhoff is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of serine protease inhibitors. With a total of 2 patents, Sommerhoff's work has implications for both diagnosis and therapy in medical applications.
Latest Patents
One of Sommerhoff's latest patents is focused on Tryptase inhibitors, specifically antistasin-type serine protease inhibitors. This invention relates to novel inhibitors derived from the medical leech Hirudo medicinalis. It includes the isolation of these inhibitors, DNA sequences encoding them, and variants obtained through recombinant DNA technology or peptide synthesis. Additionally, the patent covers pharmaceutical compositions containing these inhibitors and their potential uses in diagnosis and therapy.
Career Highlights
Throughout his career, Christian Sommerhoff has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Novartis Corporation and UCP Gen-Pharma AG. His experience in these organizations has allowed him to advance his research and contribute to innovative solutions in medicine.
Collaborations
Sommerhoff has collaborated with several professionals in his field, including Hans Fritz and Jutta Heim. These partnerships have enriched his research and expanded the impact of his inventions.
Conclusion
Christian Sommerhoff's contributions to the field of serine protease inhibitors highlight his innovative spirit and dedication to advancing medical science. His patents and collaborations reflect a commitment to improving therapeutic options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile